Have questions about Semax ?

Text us: 303-204-2469 720-499-6468

Out of stock

Semax

Nootropic Compound

Quantity

packs

1 vial
2 vial
3 vial
4 vial

Variance

10mg

Clear

Title

Discount

Buy 1

0%

Buy 2

3%

Buy 3

5%

Buy 4

10%

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is Semax?

Semax is a synthetic peptide derived from ACTH, studied for its neuroregulatory properties. Research explores its impact on BDNF expression, oxidative stress, and neural cell function. It’s commonly used in studies involving cognitive support and cellular signaling in the central nervous system.

Frequently asked questions

Products from DTC Labs do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.

In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Made in the USA

Quality controlled from start to finish. No outsourcing.

Need Help?

Send us a message.

Semax Overview

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10) with the addition of a C-terminal Pro-Gly-Pro sequence. It is studied in laboratory and preclinical models for its influence on neuroprotection, cognitive processes, and cellular stress responses. Research has investigated its ability to modulate neurotrophic factor expression, neurotransmitter systems, and oxidative stress pathways.

Ashmarin I.P. et al. (1997).

History

Semax was developed in Russia in the 1980s–1990s as part of research on synthetic peptides with potential neuromodulatory effects. It was designed to retain the neuroactive core of ACTH while eliminating hormonal activity, thereby providing a stable and non-hormonal peptide for CNS research. Over time, studies expanded into its roles in neuroprotection, synaptic plasticity, and regulation of gene expression in brain models.

Inozemtsev A.N. et al. (2008).

Research Findings

Semax has been studied in neurological, cognitive, and systemic models, with research highlighting its role in neuroprotection, cognitive function, and stress response. Studies also report activity in neurotransmitter modulation, oxidative stress pathways, and recovery processes in preclinical settings.

Key Areas of Research:

• Neurological: neuroprotection, signaling, pathways

• Cognitive: memory, learning, function

• Systemic: stress response, repair, resilience

Together, these findings suggest broad experimental potential for Semax across neurological, cognitive, and systemic pathways. By influencing neurotransmitter systems and supporting protective and restorative responses, Semax provides a versatile platform for research into cognition, stress regulation, and systemic resilience in laboratory models.

Ashmarin I.P. et al., 1995

References

Ashmarin I.P. et al. (1997). Neuroactive properties of Semax in laboratory and preclinical models. Neurosci Behav Physiol, 27(5): 570–575.

Inozemtsev A.N. et al. (2008). Semax and regulation of gene expression linked to synaptic plasticity and neuronal survival. Bull Exp Biol Med, 146(4): 439–442.

Volodina O.L. et al. (2011). Protective effects of Semax in ischemia-reperfusion injury models. Bull Exp Biol Med, 151(2): 179–183.

Text us, our dedicated team is here to help

Reach out and get a response within minutes.